The Moroccan Agency for Medicines and Health Products (AMMPS) has announced the launch of a Laboratory Information Management System (LIMS) for the National Laboratory for Drug Control (LNCM — Laboratoire National de Contrôle des Médicaments). The project marks a pivotal step in the digital transformation of Morocco’s pharmaceutical regulatory infrastructure, directly supporting the country’s ambitions to bring its drug control system into alignment with the highest international standards.
The LIMS is designed as an integrated, computerized management platform covering the full lifecycle of laboratory analysis activities. Its core functions include the end-to-end management of analytical workflows, enhanced security and traceability for analytical data, optimization of processing timelines, and reinforced interoperability with the other information systems operated by AMMPS. The system replaces fragmented manual and legacy processes with a unified digital architecture capable of supporting rigorous, auditable and efficient regulatory oversight.
The project has been made possible through financial support from the Global Fund, mobilized under a cooperation program aimed at strengthening national health systems. This international backing signals the project’s alignment with global health security priorities and Morocco’s increasing integration into multilateral health architecture frameworks. The funding source also underscores that the LIMS is not a purely administrative initiative but a component of a broader investment in the resilience and credibility of Morocco’s pharmaceutical regulatory function.
The LIMS implementation directly supports two interconnected strategic objectives. The first is achieving a high level of maturity on the World Health Organization’s Global Benchmarking Tool (GBT) — the international framework used to assess the performance and reliability of national regulatory authorities. The second is obtaining WHO prequalification for the LNCM itself, which would certify the laboratory’s technical standards to international partners and open pathways for Morocco to supply quality-assured medicines to procurement programs serving developing countries.
AMMPS described the LIMS launch as a decisive step in the ongoing modernization of the LNCM’s analytical and control tools, and as a foundational platform for the progressive integration of innovative digital solutions across the Agency. Taken together with Morocco’s World Bank-backed pharmaceutical export ambitions — including a target of multiplying pharmaceutical export revenues nearly sevenfold by 2029 — the LIMS project represents an investment in the institutional credibility without which export growth into regulated international markets would be impossible.
